The DOI matches its OpenAlex record; 41 of the 41 references it cites were found in a registry or an index.
Impact of Progestins on Estrogen-Induced Neuroprotection: Synergy by Progesterone and 19-Norprogesterone and Antagonism by Medroxyprogesterone Acetate
Abstract
Estrogen replacement therapy is associated with improvement of cognitive deficits and reduced incidence of Alzheimer's disease. To compare the impact of therapeutically relevant progestins on estrogen-induced neuroprotection, we treated primary hippocampal neuron cultures with 17beta-E2 and progestin, alone and in combination, 48 h before glutamate insult. Estrogen, progesterone, and 19-norprogesterone, alone or in combination, protected against glutamate toxicity. In contrast, medroxyprogesterone acetate (MPA) failed to protect against glutamate toxicity. Not only was MPA an ineffective neuroprotectant but it attenuated the estrogen- induced neuroprotection when coadministered. We addressed the role of MAPK activation in neuroprotection by ovarian steroids. Estrogen and all three progestins tested, alone or in combination, activated MAPK, indicating another mechanism of protection. Bcl-2 expression has been shown to prevent cell death and is up-regulated by 17beta-E2. Progesterone and 19-norprogesterone, alone or in combination with estrogen, increased Bcl-2 expression. In contrast, MPA blocked estrogen-induced Bcl-2 expression when coadministered. These results may have important implications for the effective use of hormone replacement therapy in the maintenance of neuronal function during menopause and aging and for protection against neurodegenerative diseases such as Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
Koh, J. Y., & Choi, D. W. (1987) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(87)90041-0 · Cited by 1,260
Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk
Schairer, C. (2000) · JAMA · doi:10.1001/jama.283.4.485 · Cited by 1,048
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959
Cardiovascular Health and Disease in Women
Wenger, N. K., Speroff, L., & Packard, B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307223290406 · Cited by 801
bcl-2 inhibits death of central neural cells induced by multiple agents.
Zhong, L. T., Sarafian, T., Kane, D. J., Charles, A. C., Mah, S. P., Edwards, R. H., & Bredesen, D. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4533 · Cited by 619
Henderson, V. W. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210068014 · Cited by 590
Singer, C. A., Figueroa-Masot, X. A., Batchelor, R. H., & Dorsa, D. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02455.1999 · Cited by 577
Singh, M., Sétáló, G., Guan, X., Warren, M., & Toran-Allerand, C. D. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01179.1999 · Cited by 470
Estrogen improves psychological function in asymptomatic postmenopausal women.
Ditkoff, E. C., Crary, W. G., Cristo, M., & Lobo, R. A. (1991) · PubMed · Cited by 408
Cited by
Progesterone receptors: form and function in brain
Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675
Self-citationNongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561
“Other mechanisms of neuroprotection may involve the activation of MAPK by estrogens and several progestins (334).”
BackgroundSex differences in cognitive impairment and Alzheimer’s disease
Li, R., & Singh, M. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.002 · Cited by 527
Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1008 · Cited by 429
The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications
Brinton, R. D. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.003 · Cited by 385
Self-citationSchumacher, M., Mattern, C., Ghoumari, A., Oudinet, J. P., Liere, P., Labombarda, F., Sitruk-Ware, R., De Nicola, A. F., & Guennoun, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.004 · Cited by 355
Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
Resnick, S. M., Maki, P. M., Rapp, S. R., Espeland, M. A., Brunner, R., Coker, L. H., Granek, I. A., Hogan, P., Ockene, J. K., & Shumaker, S. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2097 · Cited by 310
Steroid hormones and neurosteroids in normal and pathological aging of the nervous system
Schumacher, M., Weill-Engerer, S., Liere, P., Robert, F., Franklin, R. J. M., Garcia-Segura, L. M., Lambert, J. J., Mayo, W., Melcangi, R. C., Parducz, A., et al. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.004 · Cited by 300
Progesterone and Estrogen Regulate Oxidative Metabolism in Brain Mitochondria
Irwin, R. W., Yao, J., Hamilton, R. T., Cadenas, E., Brinton, R. D., & Nilsen, J. (2008) · Endocrinology · doi:10.1210/en.2007-1227 · Cited by 289
Self-citationMinireview: translational animal models of human menopause: challenges and emerging opportunities
Diaz Brinton, R. (2012) · Endocrinology · doi:10.1210/en.2012-1340 · Cited by 272
Sherwin, B. B., & Henry, J. F. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.08.002 · Cited by 282
Sex differences and the neurobiology of affective disorders
Rubinow, D. R., & Schmidt, P. J. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0148-z · Cited by 280
Nilsen, J., & Brinton, R. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438041100 · Cited by 262
Self-citationEstrogen Alters Spine Number and Morphology in Prefrontal Cortex of Aged Female Rhesus Monkeys
Hao, J., Rapp, P. R., Leffler, A. E., Leffler, S. R., Janssen, W. G. M., Lou, W., McKay, H., Roberts, J. A., Wearne, S. L., Hof, P. R., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3440-05.2006 · Cited by 257
Djebaili, M., Hoffman, S. W., & Stein, D. G. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.09.023 · Cited by 255
Nilsen, J., & Brinton, R. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1334098100 · Cited by 252
Self-citationNeuroprotective strategies for retinal disease
Pardue, M. T., & Allen, R. S. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.02.002 · Cited by 237
“, 2003, 2007), and have even been shown to decrease protection provided by other neurosteroids (Littleton-Kearney et al., 2005; Nilsen and Brinton, 2002).”
Frick, K. M. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2008.08.015 · Cited by 205
“…for the detrimental effects of the WHI treatment, since MPA has been shown to reduce CEE's neuroprotective effects on hippocampal neurons (Nilsen and Brinton, 2002) and to act similar to glucocorticoids (Poulin et al., 1989), which promote neurodegeneration and cognitive impairment…”
BackgroundTokushige, N., Markham, R., Russell, P., & Fraser, I. S. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.078 · Cited by 151
Progesterone and Nestorone Facilitate Axon Remyelination: A Role for Progesterone Receptors
Hussain, R., El-Etr, M., Gaci, O., Rakotomamonjy, J., Macklin, W. B., Kumar, N., Sitruk-Ware, R., Schumacher, M., & Ghoumari, A. M. (2011) · Endocrinology · doi:10.1210/en.2011-1219 · Cited by 123
Non-genomic mechanisms of progesterone action in the brain
Singh, M., Su, C., & Ng, S. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00159 · Cited by 117
Regulation of brain microglia by female gonadal steroids
Habib, P., & Beyer, C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.02.018 · Cited by 118
Kajta, M., Wójtowicz, A. K., Maćkowiak, M., & Lasoń, W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.045 · Cited by 70
Male/female differences in neuroprotection and neuromodulation of brain dopamine
Bourque, M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00035 · Cited by 40
Metadata
- Authors
- Nilsen, J., & Brinton, R. D.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2002-01
- Volume
- 143
- Issue
- 1
- Pages
- 205-212
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2034341467
- Cited by
- 342
- References
- 41
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.